Registered number: 01723353 Charity number: 326374 THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) UNAUDITED REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) CONTENTS Page Reference and administrative details of the Society, its Council members and advisers Council members. report Independent examiner's report Statement of financial activities Balance sheet 10-11 Notes to the financial statements 12-21
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) REFERENCE AND ADMINISTRATIVE DETAILS OF THE SOCIETY, ITS COUNCIL MEMBERS AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2024 Council members Dr D Roberts, President Dr G D Poole Mrs C E George Dr I Sullivan Mr R C Haggas, Treasurer Miss J Staves Mrs R Braund Dr N Osaro Mr D Gaskin (appointed 30 January 2024) Company registered number 01723353 Charity registered number 326374 Registered office CIO Armstrong Watson 1st Floor One Strawberry Lane Newcaslle Upon Tyne NE14BX BBTS Executive Manager David Noble Accountants Armstrong Watson LLP Chartered Accountants First Floor One Strawbery Lane Newcaslle Upon Tyne NE14BX Solicitors Hay & Kilner LLP The Lumen St James, Boulevard Newcastle Helix Newcaslle upon Tyne NE4 5BZ
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) COUNCIL MEMBERS. REPORT FOR THE YEAR ENDED 31 MARCH 2024 The Council members present their annual report together with the financial statements of the The British Blood Transfusion Society for the year 1 April 2023 to 31 March 2024. The report serves the purposes of both a Council members, report and a directors. report under company law. The Council members confim that the report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's goveming document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordan with the Financial Reporting Standard applicable in the UK and Republic of Ireland {FRS102) (effective 1 January 2019). Structure, governance and management a. Governing document The British Blood Transfusion Society was established in May 1983 as a company limited by guarantee governed by its Memorandum and Artides of Association (revised September 2011 }. It is registered as a charity with the Charity Commission. Every member undertakes to contribute such an amount not exceeding £1, as may be required in the event of the Society being wound up while he is a member or within one year after they cease to be a member. b. Appointment of Council members The Council members consist of officers. elected members and Past President or President Elect. Officers consist of the President of the Society who holds Offi for years and the Secretary and Treasurer who hold office for three years. The President can remain as a Council member for a further year after retirement from the office of President The Secretary and Treasurer are eligible for reappointment by Council, but neither can serve more than six consecutive years in office. The elected Council members shall be those members of the Council who are not officers and shall each hold office for a period of three years,. so far as possible they shall be made up of a mix of professional categories and be representative of the current membership; the period of office may be extended from time to time by the President for a year with a maximum of three extensions providing a maximum term of six years. The Council members of the charitable company (exduding c(FOPted members) are its directors for the purposes of company law and trustees for the purposes of charity law. The elected Council members hold offi for a period of three years. Calls for nominations for officers and elected members of Council are made in the BBTS Bloodlines Newsletter and also on the Society's website. Nominees must be UK members and must have been a member of the Society for a minimum of years. Nominations must be proposed and seconded by Society members. Details of the nominees are then published on the ballot papers. c. Induction and training of Council members All new Council members are given an induction pack containing infomation, links and papemork about the roles and responsibilities of trustees published by the Charity Commission. They also re1ve past Council meeting papers and dates of forthcoming Council meetings. At the first meeting of the new Council, new members are intrOdUd to individual Council members and specific areas of responsibility for new members are discussed and agreed. The Society's office then provides all the necessary background information and paperwork for new Council members, individual areas of responsibility.
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Structure, governance and management (continued) d. Organisation The Society is managed by the Council members, who are responsible for the strategic direction and overview of the work of the Society. The Council members must number at least eight and not more than fourteen, all of whom must be members of the Society. Three Council members (induding at least one officer) are needed for a quorum. There are committees and sub-committees of Council members that may CCpOPt members who are not members of the Council or Society. C(Fopted members may not exed thre&quarters of the total number of such committees. These committees include the Executive Working Committee, the Scientific Meetings Administration Committee, the Communications Committee and the Professional Affairs & Education Committee. The day to day operations of the charity are managed by the BBTS Executive Manager and a small team of staff from an Offi based in Manchester. e. BBTS Enterprises Limited The charity's wholly-owned subsidiary was incorporated in May 2003 and carries out trading activities for the charity. The subsidiary gift aids profits to the charity, subject to the retention of reseNes for its own working capital requirements. f. Risk management The members of the Council are responsible for overseeing the risks fad by the Society. Within this process, detailed consideration of risks is delegated to the Executive Manager. Risks are identified, assessed and controls established throughout the year. Risks are held in a risk register. Council conducts ongoing reviews of the major risks to which the Society is exposed.
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Objectives. activities and perfomiance a. Objectives and activities The main aim of the Society is to advan for the public benefit, the study of blood transfusion including immunohaematology and to promote research and development into all aspects of blood transfusion practice. The objectives of the Society continue to be to: Provide education and training, induding professional development Provide a forum for discussion and communication and facilitate the exchange of ideas beeen all groups through scientific meetings, special interest groups {SIGs) and the website Foster links with relevant national societies and organisations and ensure Society representation as appropriate Encourage research and development and disseminate information on new developments Contribute to the production of professional guidelines and promote best practice in all aspects of transfusion medicine Ensure recognition as the professional body for transfusion medicine by the government, health services and the public Contribute to the advancement of knowledge and ServIS in developing countries The Council sets itself annual objectives, in furtheran of the above main objectives of the Society. Each objective has a perf0mlan measure and responsibility is allocated to a Council member or Council sul> committee. Performan against the annual objectives is reviewed at Council meetings throughout the year and a progress report published in the Annual Review for members to view. The Council confirm that they have been given the general guidance produced by the Charity Commission on public benefit including the guidance 'public benefit running a charity (PB2)'. The Council are confident that public benefit is achieved through the study of blood transfusion and development. b. Achievements and performance The Society's charitable activities focus on the study of 00d transfusion and are undertaken to further its charitsble purposes for the public benefit as described in the following paragraphs: The Society delivered its annual conference event in October 2023. The conference was held at the Harrogate HIC. The Society met its AGM obligations to members on time. The Society continued to protect its finances during the year and worked hard for members to ensure it can continue and expand on its works and activities in the years ahead. The education programmes continue to provide valuable education and training opportunities and set out transfusion best practi. 160 people took an examination with an overall 850/0 pass rate and 76 text books were separately purchased. Our VLE software was upgraded for the third consecutive year. The Moodle exam platform software, induding online marking. perfomed well. The CPD scheme provides a specific framework for transfusion professionals. This year the Society had 522 members who were both registered and active on the scheme. CPD News continues to provide members relevant opportunities to learn and reflecL The Society continues to improve its online CPD tool for members to populate and submit returns electronically. Through engagement with all members at every step the Society has continued to work dosely with its Equality, Diversity and Indusion Committee establishing further updated Terms of Reference.
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Objectives. activities and perfomiance (continued) (continued) Successfully delivering six editions of the Society's Transfusion Medicine joumal and four editions of its membership magazine Bloodlines. The Society has continued its representations as a professional body working towards the delivery of safe and effective transfusion practice. During the year, Council achieved many of its major objectives induding the improvement of our online course delivery and online exams, maintaining a strong Transfusion Medicine impact factor and gaining a respectable financial return from this journal. The Society continues to work hard to rewrite and add to its CTP course content and now has new Course Leads. We are planning to relaunch the course in 2025. We provided one educational webinar. The Transfusion Practitioners group has appointed a new Chair and Secretary as has the Components Special Interest Group. We continued to mitigate financial risk to the Society during this period whilst remaining almost entirely financially independent. Membership of the Society has changed during the year as follows.. Number of members on 1 April 2023 Number of new members Number of members who left Number of members on 31 March 2024 1,490 191 (175) 1,506 Financial review a. Results The principal funding sources of the Society are from training income and membership subscriptions. Income from these sources is shown in note 5 to the financial statements. The net movement in funds for the year was a deficit of £5,459 (2023.. surplus £14,539), as shown in the statement of financial activities. There was a gift aid donation of £4,390 (2023.. £nil) from the subsidiary this year, so the operational deficit was £9,849 (2023.. surplus of £14,539). The group deficit for the year was £11,085 (2023: surplus £19,085). b. Reserves policy Council has established a policy whereby the unrestricted funds not committed, designated or invested in tangible fixed assets (the free reserves) held by the group should equate to at least £400,000. The reserves are needed to meet the ongoing working capital requirements of the group, to bridge any funding gaps during the development of new activities and to enable the group to continue its current activities in the event of a significant drop in income. The free reserves of the charity as at 31 March 2024 were £398,652 {2023. £403,196) and those of the trading subsidiary add a further £88,980 (2023. £94,606), a total of £487,632 (2023. £497,802).
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 c. Investment powers and policy Under the Memorandum and Artides of Association, the Society has the power to make investments as the Council members see fiL Having regard to the Society's liquidity requirements and reserves policy, Council have, in recent years, operated a policyof keeping available funds in interest-bearing deposit accounts. d. Going concem After making appropriate enquiries, the Council members have a reasonable expectation that the Society has adequate resources to continue in operational existen for the foreseeable future. For this reason, they continue to adopt the going concem basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies. Plans for future periods The Council has set itself a number of annual objectives for 2024125, in furtherance of the main objectives of the Society. These objectives indude the following.. building on the strategies for membership expansion" a written update of its Transfusion Science Practice coursebook" relaunch of its Clinical Transfusion Practi course" to deliver more online webinars- continually enhance our online exams to improve delivery and marking., bring our SIGS and their goals closer to the day to day work of Council., continue to re-enforce our relationships with other professional bodies., launch a new membership grade for non-degree transfusion workers,. introduce a new Earfy Career Professionals committee; create and launch an upgraded website and a BBTS mobile app; review the feasibility of awarding Chartered Scientist status- continue to ensure its finances are adequate following a withdrawal of funding- review alterative Conferen venues to protect our finances and reserves
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Statement of Council members. responsibilities The Council members (who are also the directors of the Society for the purposes of company lawl are responsible for preparing the Council members. report induding the Strategic report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally ACpted Accounting Practice). Company law requires the Council members to prepare financial statements for each financial year. Under company law, the Council members must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Society and of its incoming resources and application of resources, including its income and expenditure, for that period. In prepanng these financial statements, the Council members are required to= select suitable accounting policies and then apply them consistenuy., observe the methods and principles of the Charities SORP (FRS 102)., make judgments and accounting estimates that are reasonable and prudent; state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disdosed and explained in the financial statements., prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Society will continue in business. The Council members are responsible for keeping adequate accounting records that are sufficient to show and explain the Society's transactions and disclose with reasonable accuracy at any time the financial position of the Society and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Society and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Approved by order of the members of the board of Council members and signed on their behalf by.. Dr D Roberts Date: 12 September 2024
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 MARCH 2024 Independent examiner's report to the Council members of The British Blood Transfusion Society {'the Society.) I report to the charity Council members on my examination of the accounts of the Society for the year ended 31 March 2024. Responsibilities and basis of report As the Council members of the Society (and rts directors for the purposes of company law) you are responsible for the preparation of the accounts in accordan with the requirements of the Companies Act 2006 ('the 2006 Act,). Having satisfied myself that the accounts of the Society are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Society's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act,). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145{5)(b) of the 2011 Act. Independent examiner's statement I have completed my examination. I confim that no matters have come to my attention in connection with the examination giving me cause to believe: accounting records were not kept in respect of the Society as required by section 386 of the 2006 Act,. or the accounts do not accord with those records,. or the accounts do not comply wth the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fai¢ view which is not a matter considered as part of an independent examination- or the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities lapplicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 10211. I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. This report is made solely to the Society's Council members, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Society's Council members those matters l am required to state to them in an Independent examine¢s report and for no other purpose. To the fullest extent permitted by law, I do not acpt or assume responsibility to anyone other than the Society and the Society's Council members as a body, for my work or for this report Signed.. Dated: 8 October 2024 D R Gold BA FCA Independent Examiner Armstrong Watson LLP One Strawberry Lane Newcastle upon Tyne
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 MARCH 2024 Unrestricted funds 2024 Restricted funds 2024 Total funds 2024 Total funds 2023 Note Income from: Donations 4.568 13,337 257.776 24,000 28,568 13,337 257,776 38,000 4,Tt6 262,240 Investments Charitable activities Total income 275.681 24,000 299,681 304, 956 Expenditure on: Charitable activities 281.140 24,000 305,140 290,417 Total expenditure 281.140 24,000 305,140 290,417 Net (expenditure) income and movement in funds {5,459 (5,459) 14,539 Reconciliation of funds: Total funds brought fOard Net movement in funds 450,122 {5.459) 450,122 (5,459) 435, 583 14,539 Total funds carried forward 444.663 444,663 450, 122 The Statement of financial activities indudes all gains and losses recognised in the year. The notes on pages 12 to 21 fomi part of these financial statements.
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) REGISTERED NUMBER: 01723353 BALANCE SHEET AS AT 31 MARCH 2024 2024 2023 Note Fixed assets Intangible assets Tangible assets Investments 10 44,956 1,054 44,956 1,969 11 12 46,011 46,926 Current assets Debtors 13 137.115 391,329 100,972 478,541 Cash at bank and in hand 528.444 579,513 Creditors.. amounts falling due within one year 14 (123.460) (169, 985) Net current assets 404,984 409,528 Total assets less current liabilities 450,995 456,454 Capital grant (6,332) (6, 332) Net assets 444,663 450, 122 Total net assets 444,663 450, 122
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) REGISTERED NUMBER: 01723353 BALANCE SHEET (CONTINUED) AS AT 31 MARCH 2024 2024 2023 Note Charity funds Restricted funds Unrestricted funds 15 15 444,663 450, 122 Total funds 444,663 450, 122 The Society was entitled to exemption from audit under section 477 of the Companies Act 2006. The members have not required the company to obtain an audit for the year in question in accordan with section 476 of Companies Act 2006. The Council members acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements. The financial statements have been prepared in accordan with the provisions applicable to entities subject to the small companies regime. The financial statements were approved and authorised for issue by the Council members and signed on their behalf by. Dr D Roberts Mr R C Haggas Date: 12 September 2024 The notes on pages 12 to 21 form part of these financial statements.
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 General information The Society is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £1. Accounting policies 2.1 Basis of preparation of financial statements The financial statements have been prepared in accordan with the Charities SORP (FRS 102) - Accounting and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. The financial statements are prepared in sterling which is the functional and presentation currency of the charity. The British Blood Transfusion Society meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless othemise stated in the relevant accounting policy. 2.2 Income All income is induded in the statement of financial activities when the charity is entitled to the income and the amount can be quantified with reasonable accuracy. The following specific policies are applied to path'cular categories of income.. Donations are reiVed by way of grants and donations and are induded in full in the Statement of financial activities on a re1vable basis. The balan of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheeL Where income is received in advance of entitlement of receipt, its recognition is deferred and induded in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued. Income from charitable activities indudes income from membership subscriptions and training and is recognised in the period in which the Society is entitled to reipt. Deferred income represents amounts reiVed for future periods and is released to the statement of financial activities for the period for which it has been released. 2.3 Expenditure Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in setuement and the amount of the obligation can be measured reliably. Expenditure is dassified by activity. The costs of each activity are made up of the total of direct costs and shared costs, induding support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Expenditure on charitable activities is incurred on directly undertaking the activities which further the Society's objectives, as well as any associated support costs.
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 Accounting policies (continued) 2.3 Expenditure (continued) All expenditure is indusive of irrecoverable VAT. 2A Interest receivable Interest on funds held on deposit is induded when receivable and the amount can be measured reliably by the Society., this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited. 2.5 Intangible assets and amortisation Intangible assets are initially recognised at cost After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. Amortisation is provided on intangible assets at rates calculated to write off the cost of each asset on a straight-line basis over its expected useful life. The estimated useful lives are as follows= Website costs 5 years 2.6 Tangible fixed assets and depreciation Tangible fixed assets are induded in the financial statements at their historical cost. Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives. Depreciation is provided on the following basis= Fixtures and fittings Computer equipment 200/0 On straight line basis 25 % On straight line basis 2.7 Investments The investment in the subsidiary undertaking is induded in the financial statements at cosL The financial statements for the Society indude only the indivdual parent charity and are not consolidated to include the trading subsidiary. The parent charity is not required to prepare consolidated financial statements under section 399 of the Companies Act 2006 and is excepted by section 139(2) of the Charities Act 2011 from the requirement to prepare group accounts. 2.8 Debtors Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. 2.9 Cash at bank and in hand Cash at bank indudes a current account and an instant access COIF Charities Deposit Fund account
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 Accounting policies (continued) 2.10 Liabilities Liabilities and provisions are recognised when there is an obligation at the Balan sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Liabilities are recognised at the amount that the Society anticipates it will pay to settle the debt or the amount it has reiVed as advanced payments for the goods or services it must provide. 2.11 Financial instruments The Society only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value. 2.12 Fund structure General funds are unrestricted funds which are available for use at the discretion of the Council members in furtherance of the general objectives of the Society and which have not been designated for other purposes. The general fund is credited with subscriptions reiVed from members and income from training courses and associated income. It is charged with the charitable expenditure and govemance costs of the Society. Designated funds comprise unrestricted funds that have been set aside by the Council members for particular purposes. The aim and use of any designated fund is set out in the notes to the financial statements. Grants obtained for specific purposes are recognised in the financial statements as restricted funds. Investment income, gains and losses are allocated to the appropriate fund. 2.13 Judgements and key sources of estimation uncertainty In applying the Society's accounting policies, the Counal members are required to make judgements, estimates and assumptions in determining the carrying amounts of assets and liabilities. The Council members. judgements, estimates and assumptions are based on the best and most reliable evidence available at the time when the decisions are made, and are based on historical experien and other factors that are considered to be applicable. Due to the inherent subjectivity involved in making such judgements, estimates and assumptions, the actual results and outcomes may differ. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods, if the revision affects both current and future periods
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 Income from donations Unrestricted Restricted funds funds 2024 2024 Total funds 2024 Donations 4,568 4,568 24,000 Grants 24,000 4,568 24,000 28,568 Restricted funds 2023 Total funds 2023 Grants 38,000 38, 000 Investment income Unrestricted funds 2024 Total funds 2024 Total funds 2023 Bank interest 13,337 13,337 4,716 Charitable activities Unrestricted funds 2024 Total funds 2024 Total funds 2023 Membership subscriptions Training 116,532 141,244 116,532 141.244 115,109 147,131 257,776 257,776 262, 240
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 Independent examiner's remuneration 2024 2023 Fees payable to the Society's independent examiner for the independent examination of the Society's annual accounts Fees payable to the Society's independent examiner in respect of.. All other servi$ not induded above 1.228 1,170 8,833 7, 744 Total resources expended Charitable Governance Total Total activities costs 2024 2023 Direct costs Meetings and conferences Publicity and publications Bursaries and awards 1,115 6.254 97 7,355 932 7.355 932 Educational programme Modernising Scientific Careers 83,392 23,562 83,392 23,562 81,624 22,498 Allocated support costs Staff costs 110,690 38,388 641 14,274 124,964 110,606 16,182 54,570 58,179 275 916 1,130 4,326 8.652 8.287 239 797 627 35296 305140 290417 OfFice costs Depreciation Accountancy fees Legal and other professional fees 4,326 558 269 844 Stsff costs and numbers 2024 2023 Wages and salaries National insurance costs 158,991 10.724 139.638 9,017 Pension costs 178 512 154 787 Average number of employees in the year (all management and administrative)
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 Council members. remuneration and expenses During the year, no Council members reiVed any remuneration or other benefits (2023 - £NIL). During the year ended 31 March 2024, expenses totalling £761 were reimbursed or paid directly to 4 Council members (2023 - £164 to 1 Council member). 10. Intangible assets Website Cost At 1 April 2023 44,956 At 31 March 2024 44,956 Net book value At 31 March 2024 44,956 At 31 March 2023 44, 956
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 11. Tangible fixed assets Fixtures and fittings Computer equipment Total Cost or valuation At 1 April 2023 9.122 6,930 16,052 At 31 March 2024 9,122 6,930 16,052 Depreciation At 1 April 2023 Charge for the year 9.091 31 4,992 14,083 915 At 31 March 2024 9.122 5,876 14,998 Net book value At 31 March 2024 1,054 1,054 At 31 March 2023 31 1,938 1,969 12. Fixed asset investments Investments in subsidiary companies Cost or valuation At 1 April 2023 At 31 March 2024 Net book value At 31 March 2024 At 31 March 2023
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 13. Debtors 2024 2023 Due within one year Trade debtors 42.550 87,073 7.492 20.490 66,989 13,493 Amounts due from subsidiary undertakings Prepayments and accrued income 137,115 100,972 14. Creditors: Amounts falling due within one year 2024 2023 Trade creditors 3.624 3,650 1.441 114,745 11,181 4, 829 1,309 152,666 Other taxation and social security other creditors Accruals and deferred income 123,460 169,985 2024 2023 Deferred income at 1 April 2023 Resources deferred during the year Amounts released from previous periods 136,430 104,263 1136,430) 134,876 136.430 (134, 876) 104,263 136.430
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 15. Statement of funds Statement of funds - current year Balance at 31 March 2024 Balance at 1 April 2023 Income Expenditure Unrestricted funds General Fund 450,122 275.681 (281,140 444,663 Restricted funds Educational Programme Fund 24,000 124,000 Total of funds 450,122 299,681 (305,140 444,663 16. Anatysis of net assets between funds Anatysis of net assets between funds - current period Unrestricted funds 2024 Total funds 2024 Tangible fixed assets Intangible fixed assets Fixed asset investments 1,054 44,956 1,054 44.956 Current assets 528,444 528.444 (123,460) 1123,460) (6,332) 16,332) Creditors due within one year Capital grant Total 444,663 444.663
THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 16. Anatysis of net assets between funds (continued) Anatysis of net assets between funds - prior period Unrestricted funds 2023 Total funds 2023 Tangible fixed assets Intangible fixed assets Fixed asset investments 1,969 44, 956 1,969 44,956 Current assets Creditors due within one year Capital grant 579,513 (169, 985) (6,332) 579,513 (169, 985) (6, 332) Total 450, 122 450, 122 17. Principal subsidiaries The following was a subsidiary undertaking of the Society" Name Company number Pincipal place of business Class of shares BBTS Enterprises Limited 4775642 England Ordinary Holding 100°/ The financial results of the subsidiary for the year were.. Name Income Expenditure (Deficit) for the year BBTS Enterprises Limited 380,827 382,063 (1,236 Net assets 98,980